Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U.S.C. §208(b)(3) Cassandra Henderson, M.D. Committee: Reproductive Health Drugs Advisory Committee - 17-Hydroxyprogesterone caproate - Document - PDFSEARCH.IO

First Page	Meta Content
	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U.S.C. §208(b)(3) Cassandra Henderson, M.D. Committee: Reproductive Health Drugs Advisory Committee Add to Reading List Document Date: 2006-08-14 08:32:50 Open Document File Size: 12,70 KB Share Result on Facebook Company Adeza Biomedical Corporation / / Currency USD / / Organization FDA / Reproductive Health Drugs Advisory Committee / / Person Cassandra Henderson / / Position Speaker / / Product hydroxyprogesterone caproate / / Technology alpha / / SocialTag 17-Hydroxyprogesterone caproate 17-Hydroxyprogesterone Preterm birth Progesterone Endocrine system Steroid hormones Progestagens

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U.S.C. §208(b)(3) Cassandra Henderson, M.D. Committee: Reproductive Health Drugs Advisory CommitteeAdd to Reading List